Diabetes Medicine may fix prostate cancer

A group of Swedish researchers found that one of the drugs for the treatment of type 2 diabetes had very good results in solving prostate cancer.

According to the American newspaper “The New York Post”, researchers have considered previous studies of rodents before following 69 patients with prostate cancer with Type 2 diabetes.

They have found that “Biogon” to treat diabetes is that they do not suffer from the re -relaxation or development of cancer during the time of the use of centers.

Researchers have written in their studies published in the Journal of the Molecular Cancer: “Piogligan not only slow down the growth of cancer cells,” it also hinders her ability to spread. ”

“This is a very important innovation. For the first time, diabetes prostate cancer patients who have received Pipery (PPRI) have clinical notes that show that our follow -up -up period is still relaxing.”

(PPary) is an important protein involving many cellular processes, including metabolism and infections.

“These results are very optimistic, but it requires more clinical studies to diagnose the results and to investigate the opportunity to use treatment in prostate cancer with diabetes,” Kenner said.

Prostate cancer is a common type of cancer in men worldwide; It affects more than 1.4 million new cases annually.

Recently, former US President Joe Biden’s office said in a statement that he had prostate cancer when he spread to the bones.

Although the causes of prostate cancer are not known, there are many factors that increase the risk of infection. Age is a very common risk factor according to diseases control and prevention centers. Especially in some people, including the risk of prostate cancer, men with brown skin or family history. Older people aged between 65 and 74 are also likely to be infected.